Presentation on Prescription medications improving access and reducing harm. United Nations, Vienna

28 September 2023

National Forum for Police and Crime Commissioners. Presentation on prevention of drug use.

13 September 2023

Pills, thrills & bellyaches: What every psychiatrist needs to know about the rapidly changing world of young people and drug use.

11 September 2023

EMCDDA summer school: “Young people, substance use and mental health”

3 July 2023

Maudsley Cannabis Peer Group. “How do I know if I have become dependent on cannabis?”

27 June 2023

EMCDDA webinar. “Young people and drug use. How can we keep them safe?”

19 June 2023

British Army, Wellington Barracks: “Alcohol, drugs and behavioural addictions: An update”.

25 May 2023

Universities UK: “Student drug use in higher education”

18 May 2023

RCPsych London Division Eating Disorder and substance misuse

17 March 2023

Mental Health is Health

United Nations Commission for Narcotic Drugs, Vienna 2023 

14 March 2023

All party parliamentary group (APPG) New Emerging drugs and risky online behaviour trends: Clinical and Policy Implications

16 January 2023, House of Commons

RCPsych South Eastern Division Autumn Conference: Alcohol, substance misuse and the challenge of dual diagnosis in secondary care mental health services.

23 November 2022

RCPsych International Congress 2022: Substance misuse treatment: looking beyond the clinic door.

21 June 2022

Royal College of Psychiatrists, Faculty of Addiction Annual Conference

April 2022

RCPsych Addiction Faculty conference 22 : Club Drugs – an update. 

28 – 29 April 2022

Managing Drug and Alcohol Problems in Primary Care, RCGP

March 2022

Eighth international conference on novel psychoactive substances

November 2021

The Drug and Alcohol Education Conference

June 2021

A Pilot Reporting Scheme for Harms Associated with Illicit Drugs

Faculty of Addictions Annual Scientific Conference, London, April 2017

Clinical implications of novel psychoactive substances

May 2021

The International Medicine in Addiction Conference

February 2021

Commission for Narcotic Drugs: Thematic Discussions: Novel Psychoactive Substances

February 2021

September 2018 Project NEPTUNE: Novel Psychoactive Treatment UK Network. Warsaw, Poland

Warsaw, Poland, September 2018

Smoking, Drinking and Drugs

Eton College, May 2018

Project NEPTUNE: A UK Approach

United Nations, Vienna, Austria, March 2018

What parents need to know about substance misuse

Milton Abbey School, Dorset, March 2018

Club Drugs and Novel Psychoactive Substances

Andrew Sims Centre, Leeds, October 2017

The Parent-Child Environment: Talking about Drugs to Youth

iCAAD, Brussels, Belgium, October 2017

8th Annual International Psychiatric Pharmacy Conference of the College of Mental Health Pharmacy

Manchester, October 2017

19th Annual Conference of the International Society of Addiction Medicine

Abu Dhabi, October 2017

Lisbon Addictions: European Conference on Addictive Behaviours and Dependencies

Lisbon, Portugal October 2017

Old Wine in New Bottles: Seminar on the Use of New Psychoactive Substances

Brussels, Belgium, September 2017

Public Health England Annual Conference: Novel Psychoactive Substances: Where Has Their Impact Been The Greatest?

University of Warwick, September 2017

Psychoactive Substance Learning Day

HMPPS, July 2017

European Drug Summer School: Illicit Drugs in Europe

Lisbon, Portugal, June 2017

Reporting Illicit Drug Reactions (RIDR). A New Approach to Understanding NPS Harms.

Addiction National Conference, Leeds, May 2017 

Joint BASHH and FSRH Conference: Sexual and Reproductive Health Across the Life Course

Royal Society of Medicine, London, February 2017

Enhancing Inpatient Detoxification Provided by Residential Rehabilitation Services

Royal Society of Medicine, London, February 2017

Fourth International Conference on Novel Psychoactive Substances

Budapest 30 – 31 May, 2016

New Psychoactive Substances ‘No Longer a Novelty – the Expert View’

15 March, 2016

Joint `Action on Emerging and Existing Trends: Reducing Health Harms ssociated with Alcohol and Drugs

Guildhall, London, February, 2016

A New Look at Young People’s Health

Kings House Conference Centre, Manchester, February, 2016

Club Drugs Reviewing the Evidence for Treatment

3 November, 2015

International Society of Addiction Medicine: Congress Dundee

October, 2015

European Drugs Summer School

Summer, 2015

The Law’s Drugs Problem: The Challenge of Legal Highs

November, 2012

London Joint Working Group on Substance Use and Hepatitis C

November, 2010

Using a pragmatically adapted, low-cost contingency management intervention to promote heroin abstinence in individuals undergoing treatment for heroin use disorder in UK drug services (PRAISE): a cluster randomised trial. Metrebian N et al. BMJ Open July 2021 11(7): e046371

July 2021

Carfentanil on the darknet: Potential scam or alarming public health threat?

A. Negri, H. Townshend, T. McSweeney, O. Angelopoulou, H. Banayoti, M. Prilutskaya, O. Bowden-Jones, O. Corazza

International Journal of Drug Policy, Volume 91, 2021,103118, ISSN 0955-3959

May 2021

Using a pragmatically adapted, low-cost contingency management intervention to promote heroin abstinence in individuals undergoing treatment for heroin use disorder in UK drug services (PRAISE): a cluster randomised trial. Metrebian N et al. BMJ Open July 2021 11(7): e046371

May 2021

“Hot” and “Cold” Cognition in Users of Club Drugs/Novel Psychoactive Substances. Savulich G, Bowden-Jones O, Stephenson R, Brühl AB, Ersche KD, Robbins TW and Sahakian BJ. Front. Psychiatry 2021 12:660575.

March 2021

Psychiatry and the Global Drugs Debate: What Every Psychiatrist Needs to Know

August, 2019

Metrebian, N et al. (2018). Positive reinforcement targeting abstinence in substance misuse (PRAISe): Study protocol for a Cluster RCT & process evaluation of contingency management. Contemporary Clinical Trials. 71. 10.1016/j.cct.2018.06.008.

August, 2018

Wiggins H et al (2018) Demand for and availability of specialist chemsex services in the UK: A cross-sectional survey of sexual health clinics. International Journal of Drug Policy 55. 10.1016/j.drugpo.2017.12.016

May, 2018

Abdulrahim D & Bowden-Jones O. (2018) NEPTUNE: The misuse of synthetic opioids: harms and clinical management of fentanyl, fentanyl analogues and other novel synthetic opioids. Information for clinicians.

Neptune, 2018

Abdulrahim D & Bowden-Jones O (2017) NEPTUNE: Harms of synthetic cannabinoid receptor agonists (SCRAs) and their management

Neptune, 2017

Abdulrahim D & Bowden-Jones O (2017) NEPTUNE: Harms of synthetic cannabinoid receptor agonists (SCRAs) and their management

Neptune, 2017

Bowden-Jones O et al (2017). Prevalence of HIV-risk related drug use and sexual activity among men who have sex with men attending a specialist UK club drug clinic
Drugs and Alcohol Today 17(1) DOI: 10.1108/DAT-01-2017-0001

Emerald Insight, 2017

Lingford-Hughes A et al (2016). Improving GHB withdrawal with baclofen: Study protocol for a feasibility study for a randomised controlled trial.
Trials 17(1) DOI: 10.1186/s13063-016-1593-9

Trials, 2016

Abdulrahim D & Bowden-Jones O (2016) NEPTUNE: Club Drug use among lesbian, gay, bisexual and trans people

Neptune, 2016

Abdulrahim D & Bowden-Jones O (2015) NEPTUNE: Guidance on the clinical management of acute and chronic harms of club drugs and novel psychoactive substances

Neptune, 2015

Ranking the harm of non-medically used prescription opioids in the UK

December, 2015

Management of acute gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL) withdrawal: use of CIWA-Ar scoring is not sufficient in determining need for benzodiazepine treatment

British Pharmacological Society, 2015

One new drug a week. Why novel psychoactive substances and club drugs need a different response from UK treatment providers

Royal College of Psychiatrists, 2014

Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial

July, 2014

‘Legal highs’ and other ‘club drugs’: Why the song and dance?

June, 2013

An identification and brief advice programme for low-risk alcohol consumption in an acute medical setting: an implementation study

April, 2013

Acceptability and necessity of HIV and other blood-borne virus testing in a psychiatric setting

April, 2013

Patient access. How to wipe out a growing killer.

October, 2011

The prevalence of personality disorder, its comorbidity with mental state disorders, and its clinical significance in community mental health teams

April, 2010

Cambridge Textbook of Effective Treatments in Psychiatry

January, 2008

Contingency management for substance misuse

April, 2007

Prevalence of personality disorder in alcohol and drug services and associated comorbidity

October, 2004